➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Last Updated: June 13, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Darapladib

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Darapladib?

Darapladib is an investigational drug.

There have been 19 clinical trials for Darapladib. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2008.

The most common disease conditions in clinical trials are Atherosclerosis, Coronary Artery Disease, and Myocardial Ischemia. The leading clinical trial sponsors are GlaxoSmithKline, National Heart, Lung, and Blood Institute (NHLBI), and The TIMI Study Group.

Recent Clinical Trials for Darapladib
Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)GlaxoSmithKlinePhase 1
Darapladib China PKGlaxoSmithKlinePhase 1
Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy SubjectsGlaxoSmithKlinePhase 1

See all Darapladib clinical trials

Clinical Trial Summary for Darapladib

Top disease conditions for Darapladib
Top clinical trial sponsors for Darapladib

See all Darapladib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.